Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - ACURA PHARMACEUTICALS, INC | v200726_ex32-1.htm |
EX-31.2 - EX-31.2 - ACURA PHARMACEUTICALS, INC | v200726_ex31-2.htm |
10-Q - 10-Q - ACURA PHARMACEUTICALS, INC | v200726_10q.htm |
CERTIFICATION
OF PERIODIC REPORT PURSUANT TO RULES 13a-14 AND 15d-14
OF THE
SECURITIES EXCHANGE ACT OF 1934
I, Andrew
D. Reddick, the Chief Executive Officer of Acura Pharmaceuticals, Inc., certify
that:
|
1.
|
I
have reviewed this quarterly report on Form 10-Q of Acura Pharmaceuticals,
Inc.;
|
|
2.
|
Based
on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this quarterly report;
|
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects
the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly
report;
|
|
4.
|
The
registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d – 15(f)) for the registrant and
have:
|
a)
designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiary,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;
b)
designed
such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
general accepted accounting principles;
c)
evaluated
the effectiveness of the registrant's disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
d)
disclosed
in this report any change in the registrant’s internal control over financial
reporting that occurred during the registrants most recent fiscal quarter that
has materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial reporting.
|
5.
|
The
registrant's other certifying officer and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the
equivalent function):
|
a) all
significant deficiencies in the design or operation of internal controls which
could adversely affect the registrant's ability to record, process, summarize
and report financial data and have identified for the registrant's auditors any
material weaknesses in internal controls; and
b) any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal controls.
November
2, 2010
|
/s/ Andrew D. Reddick
|
Andrew
D. Reddick
|
|
Chief
Executive Officer
|